Journal profile · ONCOLOGY

UHOD-Uluslararasi Hematoloji-Onkoloji Dergisi

ISSN 1306-133X · eISSN 2412-8333 · UHOD - Uluslararasi Hematoloji Onkoloji Dergisi · TURKEY · Quarterly · Founded 2006

UHOD-Uluslararasi Hematoloji-Onkoloji Dergisi: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.31; fully open access; review over 12 weeks (community reports); community-reported acceptance: easy; 24 articles in 2025; indexed in SCIE and Scopus.

Impact factor0.31Latest value listed by LetPub
CAS zoneZone 4 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 4 · Medicine
Review timeover 12 weeksCommunity average
APC—No source gives fee information
AcceptanceEasyCommunity average
Articles per year242025 · OpenAlex count

Scope

Aims, scope and focus

UHOD-Uluslararasi Hematoloji-Onkoloji Dergisi is published by UHOD - Uluslararasi Hematoloji Onkoloji Dergisi and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Chronic Lymphocytic Leukemia Research, Chronic Myeloid Leukemia Treatments and Lymphoma Diagnosis and Treatment, together about 22.8% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

Target of Publication is the public representation of new scientific results of fundamental, problem-oriented, and search scientific investigations; analytical articles and reviews by actual scientific problems of coal mining industry, short reports in the field of coal mining industry, including the results of work of scientific meetings, conferences, summit’s and congresses in the field of mining. The basic purpose of the journal is the promotion of innovative activity in the coal mining industry by highlighting and discussing the results of basic and applied research, the experience in applying results of innovation for the development of the Russian coal mining. The most important tasks of the journal are: the generalization of scientific and practical achievements of specialists in the field of coal mining industry, specializing in the implementation of promising basic and applied research and development of priorities of high technologies; the scientific concept of the publication; the publication of the latest achievements in the field of innovation in coal mining industry. The journal lays special emphasis on methodical elaborations, analytical investigations in the sphere of coal mining. Targets of Journal are in publication of new results of scientific investigations performed by scientists, post-graduate students, and doctoral candidates performed by from higher schools, Russian Academy of Sciences, other scientific organizations of Russia, CIS countries, and foreign universities

Source: LetPub

Research area (LetPub): ONCOLOGY

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Chronic Lymphocytic Leukemia ResearchMedicine9.7%
  2. Chronic Myeloid Leukemia TreatmentsMedicine7.1%
  3. Lymphoma Diagnosis and TreatmentMedicine6%
  4. Lung Cancer Diagnosis and TreatmentMedicine6%
  5. Acute Myeloid Leukemia ResearchMedicine6%
  6. Lung Cancer Treatments and MutationsMedicine5.8%
  7. Radiomics and Machine Learning in Medical ImagingMedicine4.7%
  8. Advanced Radiotherapy TechniquesPhysics and Astronomy4.3%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorOncologyZone 4

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorOncologyZone 4

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorOncologyZone 4

Top journal: noReview journal: no

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
0.31LetPub ·
CiteScore 2026-06
0.09LetPub ·
SJR 2026-06
0.11LetPub ·
SNIP 2026-06
0.05LetPub ·
h-index
9LetPub ·
h-index
17OpenAlex ·
i10-index
32OpenAlex ·
2-year mean citedness
0.55OpenAlex ·
Self-citation rate
0%LetPub ·
Share of gold OA articles
71.23%LetPub ·

Volume

Articles per year
24LetPub ·

Articles by year OpenAlex count · 488 in total · the current year is incomplete

YearArticlesOpen accessCitations
202524247
2024202017
2023101014
2022242422
2021191918

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Average review time (community reports)
over 12 weeksLetPub ·
Average acceptance (community reports)
EasyLetPub ·

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessOpenAlex

Every article is open access; authors usually pay an article processing charge (APC).

No source has fee information yet; check the journal's website.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Publisher
UHOD - Uluslararasi Hematoloji Onkoloji Dergisi
Country or region
TURKEY
Language
Turkish
Frequency
Quarterly
Founded
2006
ISSN
1306-133X
Electronic ISSN
2412-8333
Official links

FAQ

Frequently asked questions about UHOD-Uluslararasi Hematoloji-Onkoloji Dergisi

What CAS zone is UHOD-Uluslararasi Hematoloji-Onkoloji Dergisi in?

In the 2025 upgraded edition of the CAS Journal Ranking, UHOD-Uluslararasi Hematoloji-Onkoloji Dergisi is in Zone 4 of Medicine, and in Zone 4 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of UHOD-Uluslararasi Hematoloji-Onkoloji Dergisi?

The latest impact factor listed by LetPub is 0.31; CiteScore 0.09, h-index 17.

How long does peer review take at UHOD-Uluslararasi Hematoloji-Onkoloji Dergisi?

Authors report an average review time of over 12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Which databases index UHOD-Uluslararasi Hematoloji-Onkoloji Dergisi?

According to LetPub and DOAJ records, UHOD-Uluslararasi Hematoloji-Onkoloji Dergisi is indexed in SCIE and Scopus.

Is UHOD-Uluslararasi Hematoloji-Onkoloji Dergisi open access, and what is the APC?

UHOD-Uluslararasi Hematoloji-Onkoloji Dergisi is a fully open-access journal. Fee information is not available yet; check the journal's website.

Sources and updates

The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .